Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 10.00
+0.40 (4.17%)
Jun 12, 2026, 3:00 PM CST
SHA:600267 Market Cap
SHA:600267 has a market cap or net worth of 11.58 billion as of June 12, 2026. Its market cap has increased by 11.25% in one year.
Market Cap
11.58B
Enterprise Value
12.20B
Revenue
10.31B
Ranking
n/a
PE Ratio
16.76
Stock Price
10.00
Market Cap Chart
Since August 15, 2006, SHA:600267's market cap has increased from 2.44B to 11.58B, an increase of 375.71%. That is a compound annual growth rate of 8.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 11.58B | 0.70% |
| Dec 31, 2025 | 11.50B | 18.59% |
| Dec 31, 2024 | 9.70B | -12.87% |
| Dec 29, 2023 | 11.13B | -13.94% |
| Dec 30, 2022 | 12.94B | -22.69% |
| Dec 31, 2021 | 16.73B | 4.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guobang Pharma | 12.66B |
| Nanjing King-Friend Biochemical Pharmaceutical | 12.51B |
| Shenzhen Hepalink Pharmaceutical Group | 12.33B |
| Beijing Aosaikang Pharmaceutical | 12.21B |
| Henan Lingrui Pharmaceutical | 11.73B |
| Shanghai Shyndec Pharmaceutical | 11.68B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 11.65B |
| Zhejiang Medicine | 11.38B |